Connect Biopharma Holdings Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was CNY 211.96 million compared to CNY 401.28 million a year ago. Basic loss per share from continuing operations was CNY 3.9 compared to CNY 7.3 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 USD | -4.76% | -18.37% | +35.59% |
Jun. 12 | Connect Biopharma Names New Chief Executive, Chair | MT |
Jun. 12 | Connect Biopharma Holdings Limited Announces Board and Management Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.59% | 88.16M | |
+18.15% | 124B | |
+18.02% | 112B | |
+3.70% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-16.33% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- CNTB Stock
- News Connect Biopharma Holdings Limited
- Connect Biopharma Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023